维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="ODOUX C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Endostatin plus interferon 2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunmdulatrv agents显示文摘	Moschos S J Odoux C Land S R	2007	Melanoma Res2007，17，3：	1
2	Endostatin plus interferon-alpha2b therapy for metastatic melanoma:a novel combination fo antiangiogenic and immunomodulatory agent显示文摘	MOSCHOS SJ ODOUX C LAND SR	2007	Melanoma Res2007，17，3：	1
3	Endestatin plus interferon-2b therapy for metastatic melanoma: a novel combination of antiangingenic and imunomedulatory agents 显示文摘	Moschos S J Odoux C Land S R	2007	Melanoma Res2007，17，3：	1
4	Endostatin plus interferonalpha 2b therapy for metastatic melanoma: a novel combination of antiangiogenie and immunomodulatory agents 显示文摘	Moschos SJ Odoux C Land SR	2007	Melanoma Res2007，17，3：	1
5	TRAIL,Fasl and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer显示文摘	Odoux C Albers A Amoscato AA	2002	Int J Cancer2002，97，4：	1
6	Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiongenic and immunomodulatory agent显示文摘	MOSCHOS S J ODOUX C LAND S R	2007	Melanoma Res2007，17，3：	1
7	TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small cell lung cancer显示文摘	Odoux C Albers A Amoscato AA	2002	Int J Cancer2002，97，4：	1
8	Dendritic cell biology and cancer therapy显示文摘	Whiteside T L Odoux C	2004	Cancer Immunol Immunolther2004，53，3：	1
9	A stochastic model for cancer stem cell origin in metastatic colon cancer显示文摘	ODOUX C FOHRER H HOPPO T	2008	Cancer Res2008，68，17：	1
10	A stochastic model for cancer stem cell origin in metastatic colon cancer显示文摘	Odoux C Fohrer H Hoppo T	2008	Cancer Res2008，68，17：	1
11	A stochastic model for cancer stem cell origin in metastatic colon cancer 显示文摘	Odoux C Fohrer H Hoppo T	2008	Cancer Res2008，68，17：	1
12	Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agent 显示文摘	Moschos S J Odoux C Land S R	2007	Melanoma Res2007，17，3：	1
13	A stochastic model for cancer stem cell origin in metastatic colon cancer显示文摘	Odoux C Fohrer H Hoppo T	2008	Cancer Res2008，68，17：	1
14	Endostatin plus interferon-M- pha2b therapy for metastatic melanoma: a novel combination of antian- giogenic and immunomodulatory agents 显示文摘	Moschos SJ Odoux C Land SR	2007	Melanoma Res2007，17，3：	1
15	Endostatin plus interferon-al-pha2b therapy for metastatic melanoma:a novel combination of antian-giogenic and immunomodulatory agents显示文摘	Moschos SJ Odoux C Land SR		0，，：	1
16	Dendritic cell biology and cancer therapy 显示文摘	Whiteside TL Odoux C	2004	Cancer Immunol Immunother2004，53，3：	1
17	Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agent 显示文摘	MOSCHOS S J ODOUX C LAND SR	2007	Melanoma Res2007，17，3：	1
18	Endostatin plus interferon-alpha2b therapy for metastatic melanoma:a novel combination of antiangiogenic and immunomodulatory agent显示文摘	MOSCHOS S J ODOUX C LAND S R	2007	Melanoma Res2007，17，3：	1
19	Dendritic cell biology and cancer therapy 显示文摘	Whiteside TL Odoux C	2004	Cancer Immunol Immunother2004，53，3：	1
20	HyPoxia reduces endothelin produetion by rat alveolar type Ⅱ cells in primary culture显示文摘	Crestani B Odoux C Rolland C		0，，02：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示